Home Overview Press Room Blog Publications For Students about us

Patents & Other IP : Displaying 208-217 of 413

The Myriad Breast Cancer Patent Case Continuesby Pete ShanksBiopolitical TimesAugust 1st, 2011A federal appeals court mostly overturned the lower court ruling that invalidated Myriad's patents on breast cancer genes, but further appeals are expected.
Race reemerges in debate over ‘personalized medicine’by Rob SteinWashington PostJuly 31st, 2011Federal examiners have rejected patents for genetic screening tests because the applicants did not explore their effectiveness for different races, adding to the debate about whether race has scientific validity in modern DNA-based medicine.
Ruling Upholds Gene Patent in Cancer Testby Andrew PollackNew York TimesJuly 29th, 2011The Court of Appeals for the Federal Circuit, which specializes in patent cases, said that Myriad Genetics was entitled to patents on two human genes used to predict if women have an increased risk of getting breast and ovarian cancer.
Betting That Biotech Will Bring the FDA to Heel? Don’t Count On Itby Luke TimmermanXconomyJune 30th, 2011Word is that BIO has been working behind the scenes on a series of pro-industry legislative proposals that take aim at the Food and Drug Administration, the agency with the power to make or break companies developing innovative new medical products.
A Near-Miss on Gene Patents in Congressby Doug PetBiopolitical TimesJune 23rd, 2011A House bill seeking to work around the harms of gene patents may inadvertently threaten ongoing efforts toward a ban, many advocacy and medical groups worry.
Is the Patent Office Forcing Race into Biotechnology Patents?by Jonathan Kahn, Biopolitical Times guest contributorJune 14th, 2011As we claim to be making progress toward a promised land of personalized medicine, group categories of race seem to be gaining salience in both law and science.
Doctor Abandons US Patent Application[Solomon Islands]Solomon Times April 11th, 2011The Network of the Indigenous Peoples-Solomons welcomes the abandonment of a US patent application that uses genetic samples from Solomon Islanders, in a case that raises major ethical questions.
Breast Cancer Gene Case Has Another Day in Court by Eric Hoffman and Jaydee Hanson, Biopolitical Times guest contributorsApril 7th, 2011A US appeals court hears arguments in a high-profile case challenging human gene patents.
More Arguing About Human Gene Patents in Courtby Doug PetBiopolitical TimesApril 7th, 2011A Federal Court of Appeals panel heard oral arguments in the Myriad case, but gave no hint of its decision; either way, many expect it to go to the Supreme Court.
Myriad gene patent appeal draws crowd, stirs judges by Matt CanhamThe Salt Lake TribuneApril 5th, 2011The panel of judges for the Federal Circuit questioned attorneys before a few hundred spectators, which is an unusually long time for oral arguments and an unusually large crowd.
Displaying 208-217 of 413  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760